Extracellular matrix and pathogenic mechanisms in osteoarthritis

被引：55

作者：

Hardingham T. ^{[1
]}

机构：

[1] University of Manchester, Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, Manchester M13 9PT, Michael Smith Building, Oxford Road

来源：

Current Rheumatology Reports | 2008年 / 10卷 / 1期

基金：

美国国家卫生研究院;

关键词：

Risedronate; Cartilage Oligomeric Matrix Protein; Cartilage Explants; Osteoarthritis Cartilage; Cartilage Oligomeric Matrix Protein;

D O I：

10.1007/s11926-008-0006-9

中图分类号：

学科分类号：

摘要：

Osteoarthritis (OA) is a heterogeneous condition of joint degeneration characterized by structural changes in extracellular matrices such as subchondral bone and cartilage. Research has identified many diverse ways of initiating OA, varying from mechanical disruption to gene mutations in structural proteins. A frequent end point is cartilage loss, which can occur irrespective of the initiating mechanism. Of the mechanisms responsible for cartilage matrix damage, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-5 was identified as of key importance in knockout mice, but work with human cartilage has suggested that ADAMTS-4 was also involved. A transgenic mouse expressing aggrecan lacking a key aggrecanase site clearly showed that loss of aggrecan from cartilage was an important step in both inflammatory and trauma-induced joint degeneration. In OA, cartilage chondrocytes show changes in gene expression, and it remains to be resolved if this reflects adaptive responses to changes in biological, physical, and mechanical signaling rather than any form of differentiation. Copyright © 2008 by Current Medicine Group LLC.

引用

页码：30 / 36

页数：6

共 35 条

[1]

Hardingham T.E., Articular cartilage, Oxford Textbook of Rheumatology, pp. 324-334, (2004)

[2]

Felson D.T., Lawrence R.C., Dieppe P.A., Et al., Osteoarthritis: New insights. Part 1: the disease and its risk factors, Ann Intern Med, 133, pp. 635-646, (2000)

[3]

Dieppe P.A., Research in osteoarthritis, Curr Opin Rheumatol, 18, pp. 512-513, (2006)

[4]

Ralston S.H., New developments in the search for genetic determinants of osteoarthritis, Osteoarthritis Cartilage, 15, pp. 117-119, (2007)

[5]

Aigner T., Soder S., Gebhard P.M., Et al., Mechanisms of disease: Role of chondrocytes in the pathogenesis of osteoarthritis--structure, chaos and senescence, Nat Clin Pract Rheumatol, 3, pp. 391-399, (2007)

[6]

Ameye L.G., Young M.F., Animal models of osteoarthritis: Lessons learned while seeking the "Holy Grail, Curr Opin Rheumatol, 18, pp. 537-547, (2006)

[7]

Pope F.M., Molecular abnormalities of collagen and connective tissue, Oxford Textbook of Rheumatology, pp. 301-325, (2004)

[8]

Tysoe C., Saunders J., White L., Et al., A glycine to aspartic acid substitution of COL2A1 in a family with the Strudwick variant of spondyloepimetaphyseal dysplasia, QJM, 96, pp. 663-671, (2003)

[9]

Van Camp G., Snoeckx R.L., Hilgert N., Et al., A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene, Am J Hum Genet, 79, pp. 449-457, (2006)

[10]

Brandt K.D., Radin E.L., Dieppe P.A., Et al., Yet more evidence that osteoarthritis is not a cartilage disease, Ann Rheum Dis, 65, pp. 1261-1264, (2006)

← 1 2 3 4 →